Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANAB | RXRX | NTLA | ||
| Company | Anaptysbio Inc | Recursion Pharmaceuticals Inc Cl A | Intellia Thera CS | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 55.20 | 3.25 | 11.88 | ||
| High | 57.38 | 3.27 | 12.08 | ||
| Low | 55.13 | 3.18 | 11.47 | ||
| Last | 56.61 | 3.22 | 11.94 | ||
| Change | +1.84 | +0.04 | +0.70 | ||
| Percent Change | +3.36% | +1.26% | +6.23% | ||
| Volume | 546,700 | 9,355,801 | 4,937,100 | ||
| 20-Day Average Volume | 706,935 | 19,154,225 | 4,101,910 | ||
| Previous | 54.77 | 3.18 | 11.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 55.37 | 3.10 | 11.42 | ||
| 20-Day Raw Stochastic | 32.55% | 54.29% | 49.45% | ||
| 20-Day Relative Strength | 49.82 | 49.73 | 45.95 | ||
| Weighted Alpha | +192.74 | -38.46 | +23.80 | ||
| Today's Opinion | 56% Buy | 72% Sell | 40% Sell | ||
| Yesterday's Opinion | 24% Buy | 72% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Buy | 8% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.09% since 07/31/26 | +7.33% since 07/31/26 | +11.80% since 07/31/26 | ||
| Low | 51.85 on 08/03/26 | 3.00 on 08/03/26 | 10.40 on 08/03/26 | ||
| High | 57.38 on 08/07/26 | 3.36 on 08/04/26 | 12.08 on 08/07/26 | ||
| 1-Month | |||||
| %Chg | -15.92% since 07/07/26 | -16.15% since 07/07/26 | -31.50% since 07/07/26 | ||
| Low | 49.71 on 07/21/26 | 2.84 on 07/20/26 | 10.15 on 07/28/26 | ||
| High | 70.91 on 07/14/26 | 3.90 on 07/09/26 | 17.16 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | -15.46% since 05/07/26 | -1.53% since 05/07/26 | -12.91% since 05/07/26 | ||
| Low | 49.71 on 07/21/26 | 2.77 on 05/19/26 | 10.15 on 07/28/26 | ||
| High | 70.91 on 07/14/26 | 4.09 on 07/06/26 | 18.48 on 07/02/26 | ||
| 6-Month | |||||
| %Chg | +70.75% since 02/06/26 | -19.10% since 02/06/26 | -2.77% since 02/06/26 | ||
| Low | 31.23 on 02/11/26 | 2.77 on 05/19/26 | 10.15 on 07/28/26 | ||
| High | 72.36 on 05/05/26 | 4.09 on 07/06/26 | 18.48 on 07/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,676,108 | 1,706,294 | 1,668,281 | ||
| Shares Outstanding, K | 29,608 | 529,905 | 139,722 | ||
| Annual Sales, $M | 234,600,000 | 74,680,000 | 67,670,000 | ||
| Annual Net Income, $M | -13,230,000 | -644,760,000 | -412,690,000 | ||
| Last Qtr Sales, $M | 25,560,000 | 6,470,000 | 15,050,000 | ||
| Last Qtr Income, $M | -52,880,000 | -117,500,000 | -96,230,000 | ||
| 60-Month Beta | 0.72 | 1.03 | 1.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.84 on 05/12/26 | -0.25 on 08/05/26 | -0.80 on 08/06/26 | ||
| Latest Earnings Date | 08/05/26 | 11/04/26 | 11/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||